IMHO, the SEC issue needs to occupy the time of DECNs

New Post Public Reply Private Reply Replies (1) Message Board
jrockford mrmaskedman #10562
439
IMHO, the SEC issue needs to occupy the time of DECNs lawyers and should have little to no impact on the testing validation. Two distinct issues/initiatives and should be handled by two distinct functions. Some oversight by Berman on both, but the guy is the CEO and has resources to apply to this stuff.

IMHO, and this is as straight as I can say, this companies survival as a business and credibility as a company and leadership team hinges on FDA approval of GenViro.

FDA approval alleviates SEC issues (which are a bunch of BS IMI), paves the way to disrupt a huge addressable market, opens the door for the diabetic business, ensures uplisting off greys, and offers the company numerous monetizing opportunities.

No approval and the court of public opinion will likely set this company back years in many ways. Essentially, it becomes uninvestable and illiquid.

Also, the canal crap is just that crap. These clowns exist for all stocks and esp. micro bios and even more if disruptive capability exists. I wouldn’t waste any time as a company chasing these guys. Some are paid, some are just assholes and some are just trying to make a greedy ass buck. IMO, don’t entertain them, respond to them or chase them.

So, keep the laser like focus on testing, work with the FDA and any others helping and get it done. The rest is noise and has no bearing on FDA testing validation.

That’s my straight shooting take.











Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wealth Forum Puts AI and Tokenisation Before Private Wealth

Updated Category News Views 138

Private wealth is about to get squeezed from three directions at once: younger heirs, smarter machines and assets that do not fit neatly in the old family-office binder. That is the real backdrop to the Future of Wealth Forum, a new GFTN and Luxembourg House of Financial Technology partnership slated for Luxembourg City on September 27-29, 2027. It is early days,...

Continue Reading
Hone Health’s $228M Bet on Data-Led Longevity Care

Updated Category News Views 230

Longevity medicine just got a very large check and an even larger assignment. Hone Health says it has raised $228 million to push physician-led care beyond its roots in hormone optimization, and the split of that financing matters more than the celebrity names attached to it. Only $28 million is described as Series A equity; the other $200 million comes as growth...

Continue Reading
Somerville’s New Immersive Bet Has Room to Grow Locally

Updated Category News Views 74

A passcard, a hidden door, and 12,000 square feet of mischief have landed at Somernova. Edge of Elsewhere, the new flagship attraction from Boston-area creative studio Midnight Mansion, is open in Somerville’s Union Square as of November 18, 2026. It is part interactive art installation, part puzzle game, part physical story world. That sounds delightfully odd, which is...

Continue Reading
Cold-Season Cleaning Advice Has a Practical Catch!

Updated Category News Views 53

Remote Controls Are Nobody’s First Suspect A television remote can make the rounds all evening and never see a cloth, which is precisely why Maid Brigade’s cold-and-flu-season reminder lands as common sense rather than revelation. The Scottsdale cleaning company is telling households to look past the usual kitchen counter and bathroom sink routine. Fair enough. People...

Continue Reading
Hyster-Yale’s $135 Million Convert Carries Real Cost

Updated Category News Views 63

Forklift makers do not usually get to hide a 7.50% borrowing cost behind glossy financing jargon. Hyster-Yale has priced $135 million of convertible senior notes due in 2031, lifting the deal from the originally announced $125 million. There is also an option for initial purchasers to take another $20 million. For NYSE:HY shareholders, this is not a simple debt cleanup....

Continue Reading
Dario’s Second Women’s Health Win Tests Expansion Case

Updated Category News Views 106

Midlife care just became the newest proving ground for DarioHealth’s sales pitch. The company says The Minnesota Star Tribune has expanded its existing relationship to include Dario Women™, a program for employees navigating perimenopause and menopause. Eligible employees are expected to gain access in January 2027. For NASDAQ:DRIO, this is not some grand revenue...

Continue Reading
Chemours Legal Succession Gets a Long Transition Runway

Updated Category News Views 85

A corporate-law handoff rarely sets pulses racing, but this one deserves a proper look. Chemours is replacing its long-serving general counsel while keeping the departing executive in the building for four additional months. That is not flashy, and thank goodness for that. In a global chemicals company, legal leadership touches regulation, compliance, governance,...

Continue Reading
Modexus Opens a $500 Million Buyback With Real Caveats

Updated Category News Views 155

A half-billion-dollar buyback authorization can make a stock crowd sit up fast, and Modexus Solutions has plainly chosen that moment. On November 18, 2026, the Racine, Wisconsin-based thermal-management company said its board authorized repurchases of up to $500 million of common stock. For holders of NYSE:MOD, that is a meaningful declaration of intent. It says...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 49

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
Housing's Value Equation Is Getting More Complicated

Updated Category News Views 91

A homeowner's insurance bill has become a louder market signal than a granite countertop. Green Builder Media's latest batch of research, publishing and events is aimed squarely at that uncomfortable truth: housing is no longer judged only by the price on the contract. Buyers, builders, lenders and insurers are being pushed to reckon with what a home costs to own, protect...

Continue Reading

Top 5 Most Recently Viewed Articles

AMSURG Expands Its Network with Pinnacle Surgery Center Acquisition

Updated Category News Views 950

AMSURG Expands Its Network with Pinnacle Surgery Center Acquisition AMSURG, a prominent independent leader in ambulatory surgery center services, recently achieved a significant milestone by acquiring Pinnacle Surgery Center. This acquisition boosts AMSURG's presence in the healthcare industry, particularly in providing high-quality surgical care to communities. Overview...

Continue Reading
Montauk Renewables Announces Q2 2025 Conference Call Details

Updated Category News Views 192

Montauk Renewables Schedules Q2 2025 Conference Call Montauk Renewables, Inc. (NASDAQ: MNTK), a leading renewable energy company specializing in biogas management, will host its second quarter 2025 conference call on a Thursday morning. This session is set for August 7, 2025, at 8:30 a.m. ET, where they will present their financial results for the period ending June 30,...

Continue Reading
MaxCyte Earnings Report: What Investors Should Know

Updated Category News Views 157

MaxCyte's Earnings Announcement Overview MaxCyte (NASDAQ: MXCT) is gearing up for its quarterly earnings report. Investors are keen to see the results, especially when it comes to their earnings per share (EPS) expectations. Anticipated Earnings Performance Analysts are predicting that MaxCyte will report an EPS of $-0.10. This figure is crucial as it sets the stage for...

Continue Reading
Pluxee Expands Employee Benefits with Benefício Fácil Acquisition

Updated Category News Views 239

Pluxee Strengthens Its Presence in Brazil Through Strategic Acquisition Pluxee has made a significant move to solidify its operations in Brazil by acquiring 100% of Benefício Fácil, a leading provider of employee mobility benefits. This acquisition marks a pivotal step in reinforcing Pluxee’s position within the dynamic Brazilian market. Details of the Acquisition The...

Continue Reading
Carlyle Credit Income Fund Announces Public Offering Details

Updated Category News Views 312

Carlyle Credit Income Fund Prices New Offering of Preferred Shares In a significant development in the investment community, Carlyle Credit Income Fund (the "Fund") (NYSE: CCIF) has unveiled the details of its latest public offering. The Fund has successfully priced an underwritten public offering for 1.2 million shares of its Series D Preferred Shares, which come with a...

Continue Reading